Show Menu
Choose Your Location
You are now leaving the Viatris page for a Viatris affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Viatris affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.
May 20, 2022
By: Lara Ramsburg, Head of Corporate Affairs, Viatris
As the world continues to face many challenges, including the continuing impacts of the COVID-19 pandemic, growing disparities in access to healthcare, increasing effects of climate change, and most recently, the crisis in Ukraine, we at Viatris continue to strive to be a valued partner eager to roll up our collective sleeves and make a difference where possible.
Which is why I am grateful for the opportunity to reflect on our progress and reaffirm our commitment to long-term sustainability following the release of Viatris’ 2021 Sustainability Report.
At Viatris, corporate social responsibility is at the core of our business and purpose. We are committed to sustainability through our efforts that focus on access, the environment, and diversity, equity, and inclusion (DE&I). Our commitment to access to medicine and supporting resilient healthcare systems by advancing sustainable and responsible operations truly is a collective mission, realized through the dedication of colleagues across the organization.
We’re proud that in our first full year as Viatris, we were able to commit to initial company-wide and multi-year goals, some of which include providing ARV therapy equivalent to a total of 30 million patients, including more than two million children living with HIV/AIDS, between 2022 and the end of 2025. We’ve also committed to impacting 100 million patients via healthcare professional education and outreach regarding prevention, diagnosis, and treatment options for cardiovascular, disease, diabetes, cancer, and other important chronic conditions to improve outcomes through the NCD Academy by the end of 2025. We’re also committing to reducing absolute Scope 1 and 2 greenhouse gas (GHG) emissions 42% by 2030 and reducing Scope 3 GHG emissions covering purchase goods and services, capital goods, fuel, and energy related alternatives, and upstream transportation and distribution 25% by 2030.
Here are some of Viatris’ key initiatives, progress, and accomplishments in 2021, in collaboration with our partners:
These goals and accomplishments are only possible through the collective effort of our more than 37,000 colleagues as well as great collaboration and partnership with our internal and external stakeholders.
We look forward to strengthening the foundation Viatris has built and sharing the progress we make as we continue our mission to empower people worldwide to live healthier at every stage of life, regardless of geography or circumstance.
Read the full feature story on Fortune.com.